143 related articles for article (PubMed ID: 21685330)
21. Clinical significance of angiopoietin-2 expression at the deepest invasive tumor site of advanced colorectal carcinoma.
Ochiumi T; Tanaka S; Oka S; Hiyama T; Ito M; Kitadai Y; Haruma K; Chayama K
Int J Oncol; 2004 Mar; 24(3):539-47. PubMed ID: 14767538
[TBL] [Abstract][Full Text] [Related]
22. Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia.
Hou HA; Chou WC; Lin LI; Tang JL; Tseng MH; Huang CF; Yao M; Chen CY; Tsay W; Tien HF
Leuk Res; 2008 Jun; 32(6):904-12. PubMed ID: 17904634
[TBL] [Abstract][Full Text] [Related]
23. Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.
Van der Auwera I; Van Laere SJ; Van den Eynden GG; Benoy I; van Dam P; Colpaert CG; Fox SB; Turley H; Harris AL; Van Marck EA; Vermeulen PB; Dirix LY
Clin Cancer Res; 2004 Dec; 10(23):7965-71. PubMed ID: 15585631
[TBL] [Abstract][Full Text] [Related]
24. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Nadar SK; Blann A; Beevers DG; Lip GY
J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.
Ochi N; Matsuo Y; Sawai H; Yasuda A; Takahashi H; Sato M; Funahashi H; Okada Y; Manabe T
Pancreas; 2007 May; 34(4):444-51. PubMed ID: 17446844
[TBL] [Abstract][Full Text] [Related]
26. Localized expression of angiopoietin 1 and 2 may explain unique characteristics of the rat testicular microvasculature.
Häggström Rudolfsson S; Johansson A; Franck Lissbrant I; Wikström P; Bergh A
Biol Reprod; 2003 Oct; 69(4):1231-7. PubMed ID: 12773423
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
[TBL] [Abstract][Full Text] [Related]
28. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.
Lee KW; Lip GY; Blann AD
Circulation; 2004 Oct; 110(16):2355-60. PubMed ID: 15302795
[TBL] [Abstract][Full Text] [Related]
29. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
[TBL] [Abstract][Full Text] [Related]
30. Angiopoietins 1 and 2 and Tie-2 receptor expression in human ductal breast disease.
Staton CA; Hoh L; Baldwin A; Shaw L; Globe J; Cross SS; Reed MW; Brown NJ
Histopathology; 2011 Aug; 59(2):256-63. PubMed ID: 21884204
[TBL] [Abstract][Full Text] [Related]
31. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
[TBL] [Abstract][Full Text] [Related]
32. Netrin-1 mediates early events in pancreatic adenocarcinoma progression, acting on tumor and endothelial cells.
Dumartin L; Quemener C; Laklai H; Herbert J; Bicknell R; Bousquet C; Pyronnet S; Castronovo V; Schilling MK; Bikfalvi A; Hagedorn M
Gastroenterology; 2010 Apr; 138(4):1595-606, 1606.e1-8. PubMed ID: 20080097
[TBL] [Abstract][Full Text] [Related]
33. Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis.
Kurahara H; Takao S; Maemura K; Shinchi H; Natsugoe S; Aikou T
Clin Cancer Res; 2004 Dec; 10(24):8413-20. PubMed ID: 15623620
[TBL] [Abstract][Full Text] [Related]
34. Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancer.
Szarvas T; Jäger T; Tötsch M; vom Dorp F; Kempkensteffen C; Kovalszky I; Romics I; Ergün S; Rübben H
Clin Cancer Res; 2008 Dec; 14(24):8253-62. PubMed ID: 19088043
[TBL] [Abstract][Full Text] [Related]
35. Hepatic expression of ANG2 RNA in metastatic colorectal cancer.
Ogawa M; Yamamoto H; Nagano H; Miyake Y; Sugita Y; Hata T; Kim BN; Ngan CY; Damdinsuren B; Ikenaga M; Ikeda M; Ohue M; Nakamori S; Sekimoto M; Sakon M; Matsuura N; Monden M
Hepatology; 2004 Feb; 39(2):528-39. PubMed ID: 14768007
[TBL] [Abstract][Full Text] [Related]
36. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
Zeng Y; Opeskin K; Goad J; Williams ED
Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
[TBL] [Abstract][Full Text] [Related]
37. Loss of neural cell adhesion molecule induces tumor metastasis by up-regulating lymphangiogenesis.
Crnic I; Strittmatter K; Cavallaro U; Kopfstein L; Jussila L; Alitalo K; Christofori G
Cancer Res; 2004 Dec; 64(23):8630-8. PubMed ID: 15574770
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor-D promotes growth, lymphangiogenesis and lymphatic metastasis in gallbladder cancer.
Lin W; Jiang L; Chen Y; She F; Han S; Zhu J; Zhou L; Tang N; Wang X; Li X
Cancer Lett; 2012 Jan; 314(2):127-36. PubMed ID: 22071224
[TBL] [Abstract][Full Text] [Related]
39. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
40. Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer.
Kato S; Kubota K; Shimamura T; Shinohara Y; Kobayashi N; Watanabe S; Yoneda M; Inamori M; Nakamura F; Ishiguro H; Nakaigawa N; Nagashima Y; Taguri M; Kubota Y; Goshima Y; Morita S; Endo I; Maeda S; Nakajima A; Nakagama H
Cancer Sci; 2011 Nov; 102(11):2029-37. PubMed ID: 21812859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
